ISG15-dependent stabilisation of USP18 is necessary but not sufficient to regulate type I interferon signalling in humans
View/ Open
Date
11/02/2025Author
Grant ID
SBF003/1028
101788/Z/13/Z
Keywords
Metadata
Show full item recordAbstract
Type I interferon (IFN) signalling induces the expression of several hundred IFN-stimulated genes (ISGs) that provide an unfavourable environment for viral replication. To prevent an overexuberant response and autoinflammatory disease, IFN signalling requires tight control. One critical regulator is the ubiquitin-like protein IFN-stimulated gene 15 (ISG15), evidenced by autoinflammatory disease in patients with inherited ISG15 deficiencies. Current models suggest that ISG15 stabilises ubiquitin-specific peptidase 18 (USP18), a well-established negative regulator of IFN signalling. USP18 also functions as an ISG15-specific peptidase that cleaves ISG15 from ISGylated proteins; however, USP18's catalytic activity is dispensable for controlling IFN signalling. Here, we show that the ISG15-dependent stabilisation of USP18 involves hydrophobic interactions reliant on tryptophan 123 (W123) in ISG15. Nonetheless, while USP18 stabilisation is necessary, it is not sufficient for the regulation of IFN signalling; ISG15 C-terminal mutants with significantly reduced affinity still stabilised USP18, yet the magnitude of signalling resembled ISG15-deficient cells. Hence, USP18 requires non-covalent interactions with the ISG15 C-terminal diGlycine motif to promote its regulatory function. It shows ISG15 is a repressor of type I IFN signalling beyond its role as a USP18 stabiliser.
Citation
Vasou , A , Nightingale , K , Cetkovská , V , Scheler , J , Bamford , C G G , Andrejeva , J , Rowe , J C , Swatek , K N , Schwarz-Linek , U , Randall , R E , McLauchlan , J , Weekes , M P , Bogunovic , D & Hughes , D J 2025 , ' ISG15-dependent stabilisation of USP18 is necessary but not sufficient to regulate type I interferon signalling in humans ' , European Journal of Immunology , vol. 55 , no. 2 , e202451651 . https://doi.org/10.1002/eji.202451651
Publication
European Journal of Immunology
Status
Peer reviewed
ISSN
0014-2980Type
Journal article
Rights
© 2025 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Description
Funding: This work was supported by grants from the Academy of Medical Sciences (SBF003/1028 to DJH), Wellcome Trust Institutional Strategic Support Fund (to DJH), Wellcome Trust (101788/Z/13/Z to RER), the UK Medical Research Council (MC_UU_12014/1 to JM and CGGB) and by the Wellcome Trust via a Senior Clinical Research Fellowship (108070/Z/15/Z to MPW). The UK Medical Research Council (MC_UU_00038/8 to KNS). KNS is a Lister Institute Prize Fellow.Collections
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.